GINGIVAL RETRACTION

The contract solicits a single unit of a dental gingival retraction cord kit, identified by NSN 6520-01-352-5551, consisting of one bottle each of four sizes—00, 0, 1, and 2—each containing ten feet of knitted, long interlocking chain cord designed for wet use, accompanied by a plastic organizer. The item is classified as a non-hazardous medical supply subject to stringent packaging and labeling requirements per DLA specifications, including compliance with MIL-STD-129 for marking, FED-STD-313 and TQ IP025 for hazardous material handling (if applicable), and RP001 for palletization. The product must adhere to technical and quality standards outlined in the DLA Master List of Technical and Quality Requirements, with precedence over commercial standards such as ASTM D3951. Delivery is required at the Carrier Outfitting Material Support Center in Suffolk, VA, with a five-day ADO delivery timeframe following award, under FOB Destination terms, placing full transportation responsibility on the contractor. The solicitation, issued under SPE2DH-26-T-3820, is subject to automated award processes and requires electronic submission via DIBBS by May 19, 2026. Pricing is not pre-established; offerors must provide unit pricing based on historical ranges of $23.99 to $42.48, with final contract value determined post-award. The contract includes mandatory Federal Acquisition Regulation clauses related to contract type, payment via WAWF, equal opportunity, trafficking in persons, employment verification, sustainable procurement, and hazardous material identification, as well as DFARS clauses on packaging, labeling, cybersecurity, and whistleblower rights. The Government retains full inspection and acceptance authority at the destination, and all packaging must include proper hazard labels in accordance with 29 CFR 1910.1200 unless overridden by FDA, FIFRA, or other applicable statutes. Offerors must provide UEI and CAGE codes, comply with all representations in Section K, and be registered in AMPS to be eligible for award. The contract is under the purview of the Department of Defense’s Medical Supply Chain FSH, with Tina Vu as the primary point of contact, and is governed by a streamlined acquisition framework with no formal evaluation factors published, suggesting a potential lowest-price technically acceptable award process.